NEWSROOM
Insights, events, and firm news for life sciences, pharmaceutical, chemical, and technology innovators.
HOW LIFE SCIENCES INNOVATORS ARE PROTECTING VALUE AS THE APTENT CLIFF LOOMS
As blockbuster drugs approach patent expiration, life sciences companies face significant revenue risk. Strategic patent portfolio management, validity analysis, and innovation planning can help organizations protect value and maintain competitive advantage beyond loss of exclusivity.